(Q37986131)

26 August 2017

title

Changing trends in end-stage renal disease due to diabetes in the United kingdom (English)

1 reference

26 August 2017

1 reference

C J Hill

1

1 reference

26 August 2017

D G Fogarty

series ordinal

2

1 reference

26 August 2017

publication date

1 February 2012

1 reference

26 August 2017

published in

Journal of Renal Care

1 reference

26 August 2017

volume

38 Suppl 1

1 reference

26 August 2017

page(s)

12-22

1 reference

Effects of pay for performance on the quality of primary care in England.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Temporal trends in the prevalence of diabetic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Renal allograft and patient outcome after transplantation: pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Diabetic kidney disease with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Identifying additional patients with diabetic nephropathy using the UK primary care initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Variation between centres in access to renal transplantation in UK: longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-6686.2012.00273.X

10.1111/J.1755-6686.2012.00273.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference